SS&C Technologies Holdings, Inc. (SSNC)
NEUTRALFundamental
69
Price
$83.30
Market Cap
$19.46B
Part 1 · What the company is worth
Overview
SS&C sells software and back-office outsourcing services that run the administrative plumbing of the financial and healthcare industries: fund accounting and investor reporting for hedge funds and private equity, portfolio and trading systems for asset managers and insurers, and claims and benefits processing for healthcare payers. Much of its growth has come from acquiring smaller specialist software firms and folding their clients onto SS&C's platforms.
How it makes money
Clients pay recurring fees, often for multi-year contracts, to run their fund administration, recordkeeping or claims processing on SS&C's systems, so revenue is largely subscription- and outsourcing-based rather than one-off software sales. Because these functions are central to a client's daily operations, contracts tend to be sticky, and SS&C has repeatedly used acquisitions to add both new clients and new product lines to this recurring base.
Competitive moat
Switching costs · NarrowOnce a fund manager or insurer runs its books and client reporting through SS&C's systems, moving to another provider means migrating years of records and retraining staff during a period of regulatory scrutiny, which discourages switching. The advantage is narrow because the market for financial and healthcare back-office software includes both large-scale competitors and smaller niche specialists.
What drives demand
Moderately cyclicalRecurring contract fees provide a stable base, but some revenue tied to assets under administration rises and falls with financial market levels, while healthcare-related revenue is more insulated from the economic cycle. Overall demand is moderately sensitive to how much fund and asset managers are willing to spend on outsourcing and technology.
Key risks
- Acquisition integration risk — SS&C's growth strategy relies heavily on acquiring other companies; failing to integrate their systems and clients smoothly can hurt client satisfaction and the company's reputation.
- Cybersecurity and data protection — SS&C's systems hold confidential financial and health information for clients and their end customers; a breach could disrupt operations and expose the company to liability and reputational harm.
- Fragmented, competitive market — The company faces competition from both large-scale providers with broad offerings and smaller niche players focused on specific market segments, limiting pricing power.
- Regulatory compliance burden — Operating critical infrastructure for regulated financial and healthcare clients means SS&C itself must meet a wide range of industry regulations, and compliance failures could disrupt client operations.
The case for
Buyers argue that deeply embedded, recurring outsourcing contracts across financial services and healthcare give SS&C a resilient revenue base, and that a long history of successfully absorbing acquisitions shows a repeatable way to keep adding scale.
The case against
Sellers fear that a growth strategy built on continuous acquisitions eventually runs into integration problems or pricier targets, and that competition from both large and niche software providers limits how much SS&C can raise prices on its core recurring contracts.
Written by the editors, published on August 18, 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance Sheet & Liquidity
Revenue
$6.56B
Trailing 12 months (through 6/30/2026)
Net Income
$864M
Trailing 12 months (through 6/30/2026)
Free Cash Flow
$1.66B
Total Equity
$6.89B
Total Liabilities
$13.77B
Current Ratio
1.06
Interest Coverage
3.55
Debt/EBITDA
3.63
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$76.58
Current Price
$83.30
Margin of Safety
-8.8%
Fair Value Range
$49.77 - $103.38
Estimation Methods
Valuation Metrics
P/E Ratio
24.07
ROE
11.6%
P/B Ratio
2.95
P/FCF
11.19
Gross Margin
48.1%
ROIC
8.0%
Profitability Radar
Value Creation (Economic Moat)
ROIC
8.0%
WACC
8.7%
ROIC − WACC
-0.7 pp
ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.
Fundamental Analysis Criteria
Passed (21)
- EPS shows upward trend
- EPS CAGR 15.83%
- Price CAGR 11.24%
- ROIC 8.0%
- Gross Margin 48.1%
- P/FCF 11.19
- P/B Ratio 2.95
- Debt/Equity ratio
- Operating Margin 23.6%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 12.7%
- Revenue Growth 5Y 6.1%
- Analyst Consensus 81% Buy
- Earnings Surprise avg 2.7%
- Earnings Quality (OCF/NI) 2.10
- Share Dilution -0.2%
Failed (6)
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- PEG Ratio 3.59
- Net Margin Trend 13.2% vs 13.3%
- Piotroski F-Score 4/9
Unavailable (1)
- Dividend Payout NaN%
Piotroski F-Score
Mixed signals: some areas need attention
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Governance
Executive Team
| Name | Title | Age |
|---|---|---|
| Mr. William C. Stone | Founder, Chairman of the Board & CEO | 70 |
| Mr. Rahul Kanwar CPA | President & COO | 50 |
| Mr. Brian Norman Schell | Executive VP & CFO | 60 |
| Mr. Jason Douglas White | Senior VP, General Counsel, Chief Legal Officer & Corporate Secretary | 55 |
| Mr. Anthony Caiafa | Chief Technology Officer | - |
| Ms. Justine Stone | Head of Investor Relations | - |
| Mr. Eamonn Greaves | Global Head of Sales | - |
| Mr. Ezra Baylin | Senior Vice President & Global Head of Corporate Development | - |
| Ms. Meghan Rocha | MD & Head of Global Marketing | - |
| Ms. Darpan Bhargava | Senior Vice President & Global Head of Human Resources | - |
Audit Risk
1
Board Risk
5
Compensation Risk
3
Shareholder Rights Risk
4
Part 2 · The price and when to enter
This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Latest News
Recent headlines for SSNC, sourced from Markets Gazette.